Terms: = Head and neck cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Prognosis
13 results:
1. Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progression.
Chatterjee D; Rahman MM; Saha AK; Siam MKS; Sharif Shohan MU
Comput Biol Med; 2023 Jun; 159():106944. PubMed ID: 37075603
[TBL] [Abstract] [Full Text] [Related]
2. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
3. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
Zhao H; Ling J; Huang Y; Chang A; Zhuo X
J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
[TBL] [Abstract] [Full Text] [Related]
4. Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor.
Yang Q; Wang R; Xiao W; Sun F; Yuan H; Pan Q
PLoS One; 2016; 11(2):e0148381. PubMed ID: 26839961
[TBL] [Abstract] [Full Text] [Related]
5. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Seidensaal K; Nollert A; Feige AH; Muller M; Fleming T; Gunkel N; Zaoui K; Grabe N; Weichert W; Weber KJ; Plinkert P; Simon C; Hess J
Mol Cancer; 2015 Dec; 14():204. PubMed ID: 26634247
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin.
Mielcarek-Kuchta D; Paluszczak J; Seget M; Kiwerska K; Biczysko W; Szyfter K; Szyfter W
Tumour Biol; 2014 Aug; 35(8):7441-9. PubMed ID: 24782031
[TBL] [Abstract] [Full Text] [Related]
7. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract] [Full Text] [Related]
8. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.
Durr ML; Mydlarz WK; Shao C; Zahurak ML; Chuang AY; Hoque MO; Westra WH; Liegeois NJ; Califano JA; Sidransky D; Ha PK
PLoS One; 2010 May; 5(5):e10828. PubMed ID: 20520817
[TBL] [Abstract] [Full Text] [Related]
10. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis.
Chakravarti N; Lotan R; Diwan AH; Warneke CL; Johnson MM; Prieto VG
Clin Cancer Res; 2007 Aug; 13(16):4817-24. PubMed ID: 17699860
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
[TBL] [Abstract] [Full Text] [Related]
12. [Promoter hypermethylation of tumor-associated genes in head and neck cancer].
Okami K; Sakai A; Onuki J; Hamano T; Iida M; Takahashi M
Nihon Jibiinkoka Gakkai Kaiho; 2005 Mar; 108(3):207-13. PubMed ID: 15828286
[TBL] [Abstract] [Full Text] [Related]
13. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
[TBL] [Abstract] [Full Text] [Related]
